A-A-0053623(DM)
29 August 1988
INTERIM COMMERCIAL ITEM DESCRIPTION
SUCRALFATE TABLETS
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Salient characteristics:
Shall be Sucralfate Tablets.
Shall be in accordance with the requirements of the FDA.
Shall contain 1 gram of Sucralfate per tablet within the applicable assay limits for the tablets.
All ingredients entering into the manufacture of the tablet shall be of pharmaceutical grade.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forms shall be acceptable to the FDA . The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. Tablets shall be free from defects which detract from their appearance or impair their serviceability.
Unit.
For Size 1- Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit. Bottle shall be supplied with a liquid with a child resistant safety closure.
For Size 2- Package (PG). Shall be supplied 100 tablets individually sealed in commercially available blister or strip packaging. One package containing 100 individually sealed tablets, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business